TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medipal Holdings ( (JP:7459) ) just unveiled an announcement.
Medipal Holdings Corporation reported its consolidated financial results for the first half of the fiscal year ending March 31, 2026, showing a 4% increase in net sales to ¥1,897,562 million compared to the same period last year. Despite the rise in sales, the company experienced a decline in operating profit by 7.7% to ¥25,083 million, and a slight decrease in ordinary profit by 2.3% to ¥34,269 million. The comprehensive income saw a significant drop of 29% year-on-year. The financial position indicates a slight increase in total assets and net assets, with a decrease in the net worth ratio. Cash flows from operating activities decreased, while cash and cash equivalents at the end of the period increased. Dividend payments per share were slightly increased, reflecting a stable financial strategy.
The most recent analyst rating on (JP:7459) stock is a Hold with a Yen2720.00 price target. To see the full list of analyst forecasts on Medipal Holdings stock, see the JP:7459 Stock Forecast page.
More about Medipal Holdings
Medipal Holdings Corporation is a company listed on the Tokyo Stock Exchange, primarily involved in the distribution of pharmaceuticals, health, and beauty products. The company focuses on providing comprehensive healthcare solutions and services, catering to a diverse market that includes institutional investors, securities analysts, and media.
Average Trading Volume: 421,815
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen463.5B
See more insights into 7459 stock on TipRanks’ Stock Analysis page.